7th National Congress On Genetics:'Unravelling The Secrets Of The DNA', 5-7 May 2007. by Pusat Pengajian Sains Perubatan, Pusat Genom Manusia
'di..j'"f'-# r.#e i
:9i.!lit
l*t
&
KOTA BHARU,,....,KE LANTAN, MALAYSIA
Pusol Genom Monusio
P.,usot Pengoiion Sqins
Perubqlon
PerSotuon
Genetik Moloysio
!rfr, 
' 
'lt /r r,
"i{ 
l:'
'-ie'n'
INCIDENCE OF CHROMOSOMAL ABNORMALITIES AND CLINICAL
OUTCOME IN MALAYSIAhI COUPLES EXPERIENCING REPEATED
SPONTAI\EOUS ABORTIONS
Sumita P, Siti M I, Suhaida MA: Tarmizi AB , Norhasimah M, Zilfalil BA and R
Ankathil
Humal Genome Centre, School of Medical Sciences, Universiti Sains Malaysi4l6l50 Kubang
Kerian, Kota Bhanr, Malaysia.
Parental chromosomes in couples with habitual abortions are usually not studied until other
aetiological factors have been excluded. Recent advances in cytogenetic techniques have led to
the understanding that couples with a history of more than two first trimester abortions may
carry a balanced chromosomal rearrangement leading to foetal aneuploidy and miscarriage.
Reportedly, in 5-7o/o of couples having at least 2 spontaneous abortions, one partner carries a
chromosomal rearrangement. We analysed reffospectively the karyotype patFrn and patient
profiles of 36 couples with history of repeated abortions, referred to Human Genome Centre
over the last 5 years. Results revealed chromosomal abnormalities in 4 oul'of 36 couples(ll%), a relatively higher frequency compared to earlier reports. Two patients, one male and
one female had balanced translocations namely, 45, XY,t(13;14) and 46,XX,t(5:11). Two other
patients had mosaic aneuploid karyotypes namely, 46,XXJ47,){X- tl marker chromosome and
46,XYl47,XY,+21. On analysis of the case files, the average number of spontaneous abortions
before the couples were referred for karyotyping was 4.The other investigations were mostly
normal. Ectopic pregnancies had occurred in 3 patients who however had normal karyotypes.
The prognosis in terms of having a normal baby after repeated abortions was found to be I in 3
in couples having no chromosomal abnormality and I in 4 among couples having chromosomal
abnormality. In conclusion, our study indicates that cytogenetic analysis is an important and
necessary investigation in couples with recurrent spontaneous abortions and the possibility of
prenatal diagnosis and a fair chance of achieving normal pregnancy outcome cFn be counseled
to them.
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CLINICAL AND MOLECULAR GENETIC ANALYSN OF MALAYSIAN
PATIENTS WITH DUCI{ENNE MUSCULAR DYSTROPITY
tMarini Marzuki,2salmi A- AzizrrwatihayatiM. Shamsudin, tsiti Mardaiah M. Dani,tHoh Boon Peng and 'Zilfalil Alwi
Duchenne Muscular Dystrophy (DND) is an X-linked recessive genetic disorder chancteized
by rapidly progressiva musile weakness. The cause 9f tlit disease is associaEd with several
types of mutatiins in the dystrophin gene, locatedon the X chromosome (Xp2l). Dystrophin-is
u'"o*pon nt of the plasm"-*.*bt*e cytoskeleton, which anchors and supports the
sarcolemma during exercise. Deletions account for 60% of the mutations within the 79 exons
of the dystrophin !ene. Seven exons (43,44,45,46,49,50 and 51) were found to be the most
.o-*only dileted among Asian patients. To detect the deletion of DMD, we used polymerase
chain reaction (pCR) in fatients'-samples using the 7 selected exons. A total of 20 Malaysian
male patients were analysed. The mlan ug. of initial-presentation was 60 months (SD 32
*ootd*, range 5-120 months). Fourteen patients were found to have at least one deletion in
those seven exons; deletion on exons q6, SO and 5l were the most frequent (71.43%), The
remaining six patients did not have any deletion detected on the tested exons. In view of this,
both clinical dilgrrosis and molecular analysis should ideally be performed^ fol the confirmation
of DMD. Deletion on exons 49,50 and 5i are thought to be the 'hot spot' of DMD within the
Malaysian population. Since the number of patients analysed in this study is limited' further
investigations-are essential to confirm whethir the major cause of DMD is duo to the deletion
ofexons 49,50 and5l.
lHuman Genome Centre, School of Medical Sciences,
2school of Health Sciences
Universiti Sains Malaysia Health Campus,
16150 Kubang Kerian, Kelantan
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NUCLEOTTDE 153, 104 (A TO G) RBl SNp AMONG MALAYSTAN
RETINOBLASTOMA CHILDREN AI\D THEIR PARENTS:
DISTRIBUTION AND ASSOCIATION
rllanani AY,2Noraini & rNur Shafawati Abdul Rajab,4Shuaibah AG,2Llzt-Sharmini
ATr 3Norsa'adah Bachok, aloseph Ar slai pS and tZtfatilBA
tHnm- Genome Center;2Department of Opthalmology;3unit of Biostatistics and Research
Methodology, School of Medical Sciences, 16150 Kubang Kerian, Kelantan; aHospital Kuala
Lumpur, 50586 Kuala Lumpur;sNational University of Singapore, Singapore
Retinoblastoma is an early childhood intraocular cancer, associated with the RBI gene, located
at chromosome l3ql4. The SNP at 153, 104(A)G) of RBI gene was previously reported to be
common only in Asian populations. This study attempted to determine the distribution of this
SNP in Malaysian children with retinoblastom4 their parents and confiol subjeots as well as its
association with the laterality and staging of the disease. A total of 36 retinoblastoma patients
(29 Malays, 3 Chinese and 4 Indians) and an equal number of ethnic proportions of unrelated
healthy controls were recruited. Blood samples were collected and subjected to PCR-RFLP
analysis. The presence of the minor allele of this SNP was found in 10 out of 29 Malays
patients with a frequency of 0.14. It was absent in all the three Chinese and four Indian
patients. For the healthy control subjects, this SNP was found in five out of 36 subjects with an
allele frequency of 0.07. There was no significant different between case and conhol study(p:0.147). This RBI SNP was also found in the parents of the patients with patemal and
matemal allele frequencies of 0.125 and 0.16 respectively. There was no significant association
of this SNP with laterality (t:0.468) or disease staging (p:0.545). Our results were in
accordance to the previous study done by Kadam Pai et al. (2003). A larger shrdy to correlate
this SNP with the disease is currently in progress.
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THE USM HUMAN GENOME CENTRE EXPERIENCE ON
MOLECULAR DIAGNOSTIC TESTING OF SMA CASES
rFatemeh Hayatir tWatihayati Mohd Shamshudin, tMarini Marzuki, rNur Shafawati
Abdul Rajab, tAtif Amin Baig,zzabidi-Azhar Mohd Hussin and rzilfalil bin Alwi
lHuman Genome Centre,2Department of Pediatrics, School of Medical Sciences Universiti
Sains Malaysia, 16150 Kubang Keriano Kota Bharu, Kelantan
n
Spinal Muscular Atrophy (SMA) is an inherited neuromuscular disorder and is one of the most
cofilmon genetic causes of childhood fatality. SMA is classified into three goups based on age
of onset and clinical severity. Currently, SMA is diagnosed based on clinical features and/or
muscle biopsy * electromyography (EMG). Survival Motor Neuron (SNil{) gene has been
identified as being responsible for SMA. From August 2003 until Feb 2007 we received 93
samples for SMNI gene deletion analysis from various hospitals in Malaysia. Except 3 patients
(Indonesian, Burmese, Indian), the rest were Malaysians (71 Malays, 5 Indians, 9 Chinese and
5 patients are mixed ethnicity). Muscle biopsy was performed in only 5 patients and EMG in
27 patients. DNA were extracted from blood samples using DNA extraction kit and subjected
to SMNI gene deletion analysis. Forty-nine out of 93 samples (20 type I,2l type II, and 8 type
III) were found to have homozygous deletion of at least exon 7 of the SMNI gene. Twelve
patients (7 type I, 4 type II, I type III) showed the presence of the SMNI gene and the rest
were excluded as they did not fulfrll the criteria of International SMA Consortium. Deletion of
exons 7 and 8 of the SMNI gene were found in SOVo of the SMA patients. This molecular
genetic test can be an alternative to the existing diagnostic modalities.
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IDENTIFICATION OF GENETIC IMBALAI\CES OF
NASOPHARYNGEAL CARCINOMA (NPC) BY COMPARATIVE
GENOMIC ITYBRIDIZATION (CGH): A PRELIMINARY REPORT
rHasnita bt Che Harun,2shamim Ahmed Khanr 3Hasnan Jaafar, aFauziah Mohd ldris,
sNarazah Mohd Yussof, sJames Ashman,6zulkiflee Salehuddin and tzilfalil Alwi
lHuman Genome Cenfie, 2Departrnent Of Otorinolaringology, 3Department Of Pathology,
aDepartment Of Microbiology, School Of Medical Sciences, Health Campus, Universiti Sains
Malaysi4 Kubang Kerian, Kelantan, tAdvanced Dental & Medical Institute (Clinical Cenfre),
Universiti Sains Malaysia, Pulau Pinang, 6Department Of Otorinolaringology, Hospital Raja
Perempuan Zainab II, Kota Bharur Kelantan.
Comparative Genomic Hybridization (CGH) is a molecular cytogenetic technique that was
modified from in silz hybridizationtechnique. This technique was designed to compensate the
difficulties present in conventional cytogenetic and Fluorescent In Situ Hybndization (FISH)
and is not dependent on cell culture. CGH can also be performed on archival material and it
requires no prior knowledge of the genetic aberrations. This lsshnique can be used to identiff
imbalanced genetic alterations such as deletions, gains and amplifications. Patients with
Nasopharyngeal Carcinoma (NPC), diagnosed clinically and histopathologically were enrolled
into this study. This study was conducted to identifr the pattern of genetic imbalances in NPC
in Malaysia. Tumor DNA was extracted from NPC biopsies while reference DNA was
extracted from normal controls peripheral blood. Then, tumor DNA and normal reference
DNA were tabeled by nick fianslation method with green and red fluorescent dyes,
respectively. Hybridization of red and green fluorescent labeled DNA to metaphase spread was
performed. DNA was counterstained with 4',6-diamidino-2-phenylindole (DAPI). Finally, the
image was captured and then analyzed. Chromosomal gains that were found in this study were
4q26 (20o/o) and I lql3- qla QDyi. Chromosomal losses that were observed in this study were
2Wl2 (4:0%) and l3q2l -q3l (20%). This preliminary study postulates that there may be
activation of oncogene in the gain regions and suppression of tumor suppressor gene in the loss
regions. Our findings may also, in future, provide a comprehensive profile of chromosomal
regions showing losses and gain in NPC within the Malaysian population.
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Y.CHROMOSOMAL STR VARIATION IN MALAYS OF'KELAI\TAN
AI\D MINAIIG
rNur Shafawati Abdut Rajab,lHoh Boon peng,2ooi Keat Gin and rznran Alwi
rHuman Genome Center, School of Medical Science,Health Campus, Universiti Sains
2schoor"rH,*#fl 3,ttft l!,ttfl 5jf,"^lffi;ff tfi t#rrenang,Maraysia.
E-mail address: hbpeng@kb.usm.my
Malays in Malaysia are a mixture of different races, caused by the history of migrations
centuries ago and may consist of 14 sub-ethnic groups. We used the y-chromosomal Sfn (y-STRs)-to genotlpe two of the sub-ethnic groups narnely, Kelantan and Minang Matrays. The
1T-9{ this ongoing study is to inveslig"!r__4: polymorphisms of six y-STR loci namely,DYSI9, DYS388, Dys390, Dys39l; Dys39t, and DyS393 in the two populations
mentioned. Twenty males (10 Kelantanese and l0 Minang) were analyzed by pCR
amplifications followed by tz oo"-a"outor.J pJvurryr"-ide gel electrophoresis. Randomly
selected samples were sequenced for validation. Resulis revealed a total oi 32 ull"l"s, ranginifrom three (DYSI9) to nine alleles (DYS390). Allele frequency distributions ranged from 0.05(DYS388' DYS391 and DYS393) to 0.65 (DYS388). The highest gene frequency of 0.6 wasfound in Kelantan Malays [DYS3S8 (l27bp); oy3ggt (l63bp)] while for Minang it wasDYS388 (l27bp) with a frequency of 0.7. Rttnougtr the ievel^oipolymorphism of the twopopulations are similar the number of alleles (4); f,eterozygosity (0.6) and allelic fiequencydistributions appeared to be imbalanced. Signincant diffeiences of allele tequency
distributions were observed in loci DYS390 (l99bp), DyS39t (t67bp) and DyS393 (l32bp).Surprisingly, none of the individuals shared the sime haplotypes. However, errors of scorni
and factors like small sample sizes should be coosid"r"i. neliminary result revealedpolymorphisms in the six loci among the two Malay sub-ethnic groups. Signifrcant differences
of the allelic frequency distributions were obserurd, b.rt u furt'irq invesfrgation with larger
sample sizes is warranted to confirm these findings.
3l
(3
f
e
d
g
ry)f
P.
P-
ift
on
nd
nts
SMN2 COPY NUMBER OF MALAYSIAII SMA PATIENTS WITH
HOMOZYGOUS DELETION OF SMN1
tWatihayati Mohd Shamshudin, aTeguh Haryo Sasongko,3Tang Thean Hock, Zabidi2Azhar Mohd Hussin, aHisahide Nishio ana rZittatil Alwi
lHuman Genome Center, 2Department of Pediatrics, School of Medical Sciences,
Health Campus, 3lnstitute for Research in Molecular Medicine,
Universiti Sains Malaysia, Pulau Pinang, Malaysia,
.oDivision of Public Health, Kobe University Graduate School of Medicine, Japan.
SMA is an inherited neuromuscular disorder caused by homozygous deletion of SMNI gene.
Deficiency of survival motor neuron protein causes the degeneration of anterior horn cells in
the spinal cord leading to progressive muscle wealaness. SMA has been classified into 3
clinical subtypes based on age of onset and clinical severity. Type I is the most severe while
type III is the mildest form. More than 90%o of SMA patients have deletion of SMNI gene
irrespective of disease severity. However, patients with homozygous deletion of SMNI gene
retain at least I copy of the duplicated gene, SMN2. The copies of the SMN2 gene were
reported to be inversely proportional with the severity of the disease. In this study, we
performed a quantitative PCR analysis in 35 SMA patients (12 typel, 17 type II and 6 tpe III)
with homozygous deletion of SMNI gene to determine the copies of SMN2 gene. The DNA
was extracted from the blood using GeneAll@ DNA extraction kit. CFTR and SMN2 genes
were then amplified using LightCyler@ real-time PCR machine and SYBR@ Green I
fluorescent dye. The SMN2 copies were calculated relative to the CFTR of each sample. The
majority (83%) of type I patients showed 2. copies, 94% of type II showed 2 and 3 copies and
100% of tlpe III showed 3 and 4 copies of the SMN2 gene. The copy number of SMN2 in our
SMA patients indicated a close relationship between the gene and clinical severity of patients.
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MUTATIONAL ANALYSIS OF II-RAS GENE IN ORAL CAIICER
PATIENTS TREATED IN HOSPITAL UNIVERSITI SAINS MALAYSIA
uFarinil MS, l'Azlina Ar 3shaharum S and lsamsudin AR
lSchool of Dental Sciences, 2Human Genome Center, School of Medical Sciences, 3School of
Health Sciences, Universiti Sains Malaysia
H-ras gene is a proto-oncogene that encodes for membrane-bound protein known as p2lras,
which plays an important role in signal transduction and cell proliferation. Point mutations may
convert this proto-oncogene into oncogene, which, in turn leads to the development of cancer
through complicated cascade events. Mutated H-ras gene has been identified in various human
cancers, including oral cancer, primarily located at the exon I (codons 12 and 13) and at low
frequency, at the exon 2 (codon 61). This study was conducted to investigate the presence of
mutations at exons I and2 of the H-ras gene in 30 cases of oral cancer using Polymerase Chain
Reaction-Restriction Fragment Length Polymorphism (PCR-MLP). DNA was extracted from
surgically removed oral cancer tissue and subjected to PCR amplification. Digestion was
performed using Msp I and BstN I restriction enzyme for exons I and 2 respectively. Two
cases (7%) showed mutations at the codon 12 of exon 1, whereas no mutations were detected
in codon 6l of exon 2 of the H-ra-s gene. Compared to the frequency of codon 12 mutations
reported in western (<syo),India (357o) and Taiwan (%) populations, these results suggest that
H-ras gene may play a role in the oral carcinogenesis. However, larger sample size and
sequencing are required to yield more precise results.
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APPLTCATTON oF'DHPtc FoR SCREENING oF GJB2 MUTATIONS
AM.NG MALAYT 
YflTilPil,fi)t-5?ffiHEARTNG Loss: A
tsiti AishahZainalrtMohd Khairi Md Daud,3Normastura Ab Rahamn,
aZafarina Zianuddin and rzilfalil AIwi
tHuman Genome Center;
2Department of Otorhinolaryngology, School of Medical Sciences;3school of Dental Sciences;
aschool of Health Sciences, 16150 Kubang Kerian, Kelantan.
Hearing loss (Hl) is the most common congenital sensory defect in human affecting
approximately 1:1000 newborns worldwide. Hl can be caused by environmental and genetic
factors. Genetic causes represent 50-70% of Hl of which 80o/o are autosomal recessive. Many
genes are involved in the non-syndromic hearing loss (NSHL). Several of these genes have
been identified an{ mutations in the GIB2 gene (13q1 l-ql2.l), encoding gap junction protein
connexin 26 (Cx26) have been confrmed to be responsible in a majority of the patients. The
objective of this study was to screen mutations in the coding region of GJB2 gore. A total
number of 33 NSHL Malay patients were screened for mutations in the Cx26 coding region.
The DNA was exhacted from buccal swabs using GeneAll@ DNA extraction kit and subjected
to PCR. The fragments were then electrophoresed and slow -reannealing was performed,
followed by screening using denaturing high performance liquid chromatography. Eight out of
the 33 samples showed heterozygous peaks indicative of presence of mutations.
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CONSTRUCTION OF GENETICALLY ENGINEERED LIVE
ATTENUATED NON TOXIGENIC, AUXOTROPHIC Vibrb cholerae
tAtif Aminr 2sinnah Kurunathanr 3zainul F. Zainuddin and 2Ravichandran. M
tHoman Genome Centre, School of Medical Sciences, Universiti Sains Malaysia,
2Dept of Microbiology & Parasitology, School of Medical Sciences, Universiti Sains Malaysia,
'School of Health Sciences, Universiti Sains Malaysia
16150, Kubang Keriarl Kota Bharu, Kelantan
E-mail address : atifameen@hotuail.com
Cholera is an epidemic, endemic and the only pandemic bacterial disease and is caused by
gram negative bacteria, Tibrio cholerae. Therapies against cholera are available but the ideal
approach is to prevent cholera. Cholera can be prevented by improved sanitations or by
vaccination against V. cholerae. Since sanitation is not possible on a large scale so oral live
attenuated cholera vaccines are the ideal choice for cholera prevention beoause of ease of
adminishation and their natural; acquired active immunogenic response. This study reflects the
construction of genetically engineered live attenuated non toxigenic auxotrophic V. cholerae
vaccine candidates, VCUSM5 and VCUSM6. These vaccine sfiains are metabolic auxofrophs
of amino levulinic acid (ALA) because of the mutation in the hemA gene. This auxotrophy in
VCUSM5 was achieved by the insertion mutation of the aphA cassette into hemA that codes
for gutamyl tRNA reductase, an important enrqe of the C5 pathway of ALA biosynthesis. In
the case of VCUSM6 auxotrophy was achieved by frame shift mutation in hemA. Colonization
assay with infant mice showed that the vaccine candidates are good colonizers of the small
intestine. These vaccine candidates were found to be the least reactogenic in the rabbit ileal
loop assay and this was confirmed by histopathological examination of the ileal loops. The
vaccine candidates are environmentally safe and cannot survive longer than 4-5 days in
environmental waters as compared to the wild type which survives more than 15 days in water
samples. All the above results show that VCUSM5 and VCUSM6 are the promising least toxic
and safe vaccine candidates.
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TRISOMY9-ACASEREPORT
rTP Kannan, 25 lremhthtrrW:r.Azman, rMA Nor Atifah, lAB Ahmad Tarmizil,tsiti Mariam, rMA suhaida, rMM Nor Hasimah, 1A Ravindran and rBA zilfalii
lHuman Genome Centre, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia2Hospital Raja PerempuanZainabll, Kota Bharu, Kelantan, Malaysia
Trisomy 9 is a rare chromosomal disorder in which the entire chromosome nine appears three
times rather than twice in cells of the body. This can occur either as a mosaic or non-mosaic
pattem and may be caused by errors during the division of parental reproductivo cells (meiosis)
or during the division of body tissue cells (somatic cells) early in the development of the
embryo (mitosis). We report a case in which the infant showed the characteristic phenotSpes of
a small face, wide fontanelle, prominent occiput, micrognathia" low set ears, upstanting
palpebral ftssures, high arched palate, webbed neck, short sternunr, overlapping fingers, limited
hip abduction, rocker bottom feet and heart murmurs. Cytogenetic analysis done on the blood
of the patient confirmed the presence of non-mosaic fiisomy 9. Non-mosaic or complete
trisomy 9 is a lethal diagnosis, with most fetuses dying prenatally or during the early postnatal
period and most of the cases end in spontaneous abortion in the first trimester. Ilowever, in the
present case, the infant survived lumttil20 days after birth. This report adds to the literature of
cases of trisomy 9 live-born infants that survived beyond one week.
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DUPLICATION 9(Q12Q13): A NEw VARTANIT oF DUPLICATION 9e
SYNDROME?
Azman BZ, Ravindran Ankathil, Suhaida MA Siti Mariam I, Norhashfunah l\d, Tarmizi
AB and Zilfalil BA.
Human Genome Centre, School of Medical Science, Health Campus, Universiti Sains
Malaysia, Kubang Kerian, Kelantan Malaysia
We report a case of a two year -old Malay boy who presented with facial asymmetry, small
and malformed left ear pinna, left hearing impairment and high arched palate. He was born full
term with a birth weight of 3.1 kg to non - consanguineous Malay parents. At birth, his mother
and father were aged 32 and 39 years respectively. There was no similar family history of note.
His developmental milestones were appropriate for age. An initial diagnosis of Gotdenhar
syndrome was made until cytogenetic analysis revealed a karyotlpe of 46,YY,
dup(9)(q12q13). In our patient, duplication involved only the proximal region (ql2ql3) of the
long arm of chromosome 9. Our patient did not present with feanres typical of duplication 9q
syndrome and appears to have a better prognosis. To the best of our current knowledge, this is
the first case report of duplication 9q that solely involved the proximal part of the long arm of
chromosome9 (ql2ql3) which could be a new variant of duplication 9q syndrome.were
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DOWI\ SYI\DROME AS A RESULT OF ROBERTSOI\IIAhI
TRANSLOCATION INVOLVING CHOROMOSOME 14 AND 21: A
CASE REPORT
Norhasimah MM, Ahmad Tarmizi AB, Azman BA, Zilfalil BA, Ravindran Ankathil
Human Genome Center, Universiti Sains Malaysia,Kubang Kerian,Kelantan.
Generally, the karyotype profile of Down Syndrome has been reported to be full trisomy 2l in
92o/o of patients, mosaic trisomy 2l in 4%o of patients and translocation invoMng chromosome
2l in 4Yo of patients in most of the population groups worldwide. But, karyot5rpe analysis of
149 DS patients at the Human Genome Center, USM, during the past five years revealed that
free trisomy accounted for 94.60/o, mosaic trisomy 2l for 4.7%o and translocation involving
chromosome 2l in0.7%o of the Down Syndrome etiology in North East Malaysian population,
indicating a low frequency of fianslocation DS in this region. Here, we report one case of
translocation Down Syndrome encountered during karyotype analysis of I49 DS cases. The
patient was a young male aged 2 months, born as a third child to young parents aged 28(F) and
26(M) years, who were referred to Human Genome Center, USM, for cytogenetic analysis. The
child has clinical features like flat facial proflrle, epicanthic folds, flat nasal bridge, convergent
strabismus, single simian crease , etc to be suspected as a case of Down Syndrome.
Chromosome analysis was caried out employing short term micro culture of the peripheral
blood lymphocytes of the patient at 37"C for 72 hours, harvested by standard cytogenetics
procedures and karyotypes from GTG banded metaphases were prepared foltowing standard
procedures. Chromosome analyses of the parents were also done similarly. Analysis of 20
GTG banded metaphases of the patient showed 46,YY,+ 21, der Qa;2D (ql0iqlO) karyotype
pattern in all the metaphases. Karyotype showed a Robertsonian fianslocation where an entire
exha chromosome 2l was attached to the centromere of one of the chromosome 14, resulting
in a derivative chromosome 14 with attached chromosome 21. Karyoqpe analysis of the
parents revealed a normal 46,XY pattern for the father and 46,XX pattern for the mother.
Translocation Down Syndrome may arise either de novo or as a result of inhreritance from a
balanced translocation carrier parent. As the parents of this DS child ghowed normal
karyotypes, it can be concluded that this Robertsonian translocation had arisert de novo either
prior to or at conception. In cases of de novo Robertsonian translocation, the risk of DS in a
subsequent pregnancy is estimated to be 2-3%. However, in translocation DS, karyotlrying of
the parents should be done compulsorily to determine the origin of the translocation and for
proper genetic counseling.
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CYTOGENETIC AIID MOLECULAR GENETIC ANALYSN IN ACUTE
MYELOID LEUKEMIA (AML) PATIENTS
lSuhaida Md Akhir, rSiti Mariam Ismailr rAzman BZ, 2RosHne Hassanr 2Thanaseelan P.,
rZilfalil BA and lRavindran Ankathil
tHuman Genom Center, Universiti Sains Malaysia, Kelantan, Malaysia
2Dept of Haematology, Universiti Sains Malaysia, Kelantan, Malaysia
It has been well established that Acute Myeloid Leukemia (AI\tr ) is a very heterogeneous
disease at both the cytogenetic and molecular genetic levels. Some of the FAB subt)rpes are
associated with specific genetic alterations, which can be detected at the cytogenetic level as
consistent chromosome abnormalities or at the molecular level as consistent fusion gene
transcripts. Because cytogenetic findings are among the most important prognostic factors,
cytogenetic analysis of bone marrow samples is now mandatory in the diagnostic workup of
newly diagnosed patients with AML. The presence of fusion genes associated with specific
chromosome translocations can be detected by molecular techniques. At the Hospital
Universiti Sains Malaysia (HUSM), cytogenetic and molecular genetic investigations are
undertaken routinely for the diagnostic workup of AML patients. During the period from 2003
to 2006, bone marrow samples of 104 AML patients were analyzed at the Human Genom
Center, USM , for the presence of specific and nonspecific numericail and structural
chromosome abnonnalities. Among these 104, 50 samples were analyzed for the presence of
AMLI/ETO, PML/RARa and CBFBiIvIHYI I fusion genes at the Haematology Department,
HUSM, employing RT PCR. Out of the 104 samples analyzed cytogenetically, 54 (52 o/o)
showed normal karyotypes, 30 (29 %) showed abnormal karyotypes and 20 samples (19 o/o)
failed to give satisfactory chromosome preparations. FAB subtlpe specific as well as
nonspecific chromosome abnonnalities were observed. Out of the 50 samples analyzed for
molecular genetic alterations, 22 (44Yo)were negative, l5 (30 %o)were AML/ETO positive, 12
(24 %) were PML/RARa positive and I Q W was CBFB/IvtYHll positive. In few cases
which failed to give satisfactory cytogenetic results, molecular genetic analysis could provide
data on the underlying molecular genetic alteration. Through cytogenetic analysis, both
specific chromosome abnormalities associated with specific FAB subtypes of AML as well as
other random chromosome abnormalities present in the leukemic cells could be detected. So
both cytogenetic analysis as well as molecular genetic analysis are important for the diagnostic
and prognostic workup of AML patients.
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TWO DIFFERENT, THREE WAY COMPLEX, VARIAT',{T
PHILADELPIIIA CHROMOSOME TRANSLOCATION IN TWo
PATIENTS WITH CHRONIC MYELOID LEUKEMIA
lSiti Mariam Ismail, lSuhaida Md Akhiro lAzman BZ, 2Rosline llassan,lZilfalil BA andlRavindran Ankathil
lHuman Genom Center, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
2Dept of Haematology, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
Chronic Myeloid Leukemia (CML), is a clinical myeloprol liferative disorder involving the
pluripotent stem cell. The hallmark of CML is a karyotypic marker, the Philadelphia ( Ph )
Chromosome, originating from areciprocal ( 9 ;22) (q34; qll ) translocationbetween
chromosome 9 and 22 and genetically resulting in a fusion BCR 
-ABL gene. Variant Ph
translocations derived through other rearangements rarely occur. Here we present two cases
of Chronic Myeloid Leukemia with variant Ph hanslocations. Both cases have been diagnosed
clinically and haematologically as CML. Karyotype analysis employing GTG banded
metaphases of the bone marrow samples of these 2 patients showed complex translocations
involving 3 chromosomes. Case 1, a female aged32 years, showed 46 ,XX, der ( 21) t (9;21;
22 ) ( q34; ql3; qll ) karyotype pattern. The second case, also a female, aged 39 years,
showed 46, XX, der (22) t (5 ; 9 ;22 ) ( qll; q34;qll ) karyotype pattern. Both
karyotypes were suggestive of variant Philadelphia translocation cytogenetically, which was
later confirmed through molecular analysis for bcr-abl fusion gene transcripts. Complex
chromosome translocations usually involving exchanges between three or more
chromosomes, may be formed by multiple simultaneous breaks or some may arise as a result
of two or even more, genetic events in close association. Both conventional cytogenetic
techniques and molecular genetic techniques are important in identiffing variant Philade$hia
chromosome translocations in chronic myeloid leukemias.
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SCRBENING T'OR BETA-GLOBIN MUTATIONS BY PCR.RFLPAMONG KELANTAN MALAYS WITH BETA-THALASSEMIA MAJOR
rNoratif Arr Mohd Adam, rMqhc Nizlm 7.aha\t rNur shafawati AB Bajab,2Rozitah AHRazman, 2Arilin Nasir,'atia" i".ahap,3sangkot Marzuki and rzitfalil Alwi
tHuman Genome c:lo..,2Department of Pediatrics, school of Medical science universitisai19 Maraysia, 16150 Kubang Kerian, rota gharu, Kelantan.
'Ei;krnan Instiiute for Molecu.i* t;i;;,iux^*,Indonesia.
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Beta-thalassemia major is an autosomal recessive disorder characteized by severehlpocbromic microcytic anemia. Beta+halassemia occurs as a result of mutation in the ftglobin gene (HBB) which is located on ctromoro*r-il. over 200 mutations have beenreported in association with thalassemia. Six common mutations in the Marlay population werestudied which were fVS-l nt5 (G-+c), IVS-I ntl (G-+f), codon 26 (G+A), codon lg(A-G), codon 15 (G-+A) and codon 4l_4.2(a bp del). A cross sectional study was conductedin 35 Kelantan Malay p-thalassemic patienis who attended the Hospihl Universiti SainsMalaysia' DNA was extracted from utood and subject Jlo pcn amplification. The ampliconswere then digested with six restriction enzymes, cacgl, BslI, Ahi ai;i;-ltu and TaqI todetect the presence of these mutations. r'ive mutation; were detected namely, fVS-l nt5(G-+C), IVS-I ntl (G-+T), codon 26 (G-+A), codon 4l_42(a bp del) and codon 19 (A_+G).one mutation in codon 15 (G=+{) was not detected. Among these, the two most commonmutations were codol 26 Q-+A) and IVs-l nt5 (G+c), which accounted for 74.3yo and48'6% respectively' None oith" six mutations were detected in two patients, our results add tothe existing data on th1c91mon Bglobin gro, .;atioo, 
"-orrg the Kelantan Malays. Alarger sample size is needed to confinittt".pErt u- orB-ii"r*semia mutations and its clinicalimplications among this Malay rrl"i, goup.
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